The invention provides a vaccine composition for transdermalor transmucosal administration for inducing cellular immunity,comprising (i) an antigen; and (ii) a pharmacologicallyacceptable acid or a pharmacologically acceptable salt thereofas a first cellular immunity induction promoter.